Related Experiment Video

Updated: May 13, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

FHIT: from gene discovery to cancer treatment and prevention

Yuri Pekarsky1, Nicola Zanesi, Alexey Palamarchuk

  • 1Kimmel Cancer Center, Thomas Jefferson University, PA 19107, USA.

The Lancet. Oncology
|December 11, 2002
PubMed

Insights

The FHIT gene, located on chromosome 3p14.2, is frequently inactivated in many cancers due to chromosomal abnormalities. Recent research supports its role as a tumor suppressor, offering new avenues for cancer treatment and prevention.

Area of Science:

  • Genetics and Molecular Biology
  • Oncology
  • Cancer Research

Background:

  • Chromosomal abnormalities like deletions and loss of heterozygosity are common in human tumors.
  • The 3p14.2 region of chromosome 3 is a frequent site for these rearrangements and contains the FHIT gene.
  • The FHIT gene is often inactivated in various common human cancers.

Purpose of the Study:

  • To review recent findings in the molecular biology of the FHIT gene.
  • To explore the tumor suppressor function of FHIT.
  • To highlight opportunities for cancer treatment and prevention based on FHIT research.

Main Methods:

  • Review of accumulated scientific literature on FHIT gene and its role in cancer.
  • Analysis of chromosomal aberrations involving the 3p14.2 region.
  • Evaluation of evidence supporting FHIT's tumor suppressor activity.

Main Results:

  • FHIT gene inactivation is a common event in numerous human malignancies.
  • Substantial evidence supports FHIT's function as a tumor suppressor.
  • Research has identified FHIT as a key player in the development of various cancers.

Conclusions:

  • The FHIT gene is a critical tumor suppressor frequently altered in human cancers.
  • Understanding FHIT's molecular biology opens potential pathways for novel cancer therapies.
  • Targeting FHIT may offer new strategies for cancer prevention and treatment.

More Related Videos

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries10:10

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries

Published on: March 31, 2019

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
FISH - Fluorescent In-situ Hybridization02:07

FISH - Fluorescent In-situ Hybridization

Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...